Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivipansel in Sickle Cell Vaso-Occlusive Crisis
NCT01119833Phase 2Completed
- Sponsor
- GlycoMimetics
- Start
- May 2010
- Primary completion
- Dec 2012
- Modality
- Bivalent/Multivalent Binders, Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of rivipansel in sickle cell disease (SCD), sponsored by GlycoMimetics. Started May 2010; status: completed.
02
Drugs
rivipansel
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT01119833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01119833.